跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
TRESIBA
Authorized
STANDARD
TRESIBA
Novo Nordisk Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1795f8d774b79788
Company
Novo Nordisk Canada Inc
Type
Standard
Approval Details
Approval Id
1795f8d774b79788
Drug Approval Canada Name
TRESIBA
Product Name
TRESIBA
Status
Marketed
Status Date
2023-01-30
Original Market Date
2023-01-30
Din
02467860
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D
Ahfs
68:20.08.16
Atc Original
A10AE06 INSULIN DEGLUDEC
Atc Name
a 10 ae 06
Aig Number
0159410001
Company Name
Novo Nordisk Canada Inc
Company Address
101-2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1
Active Ingredients
INSULIN DEGLUDEC
100 UNIT / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1795f8d774b79788
Type
Standard
Back to Health Canada Approvals
TRESIBA - Health Canada Drug Approval Details